Oncolytics Biotech Inc (NASDAQ: ONCY) — Healthcare · Share Price, Chart & Market Data
About: Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.03 (-5.50%)
ONCYOncolytics Biotech Inc
Loading watchlist status…
Trade ONCY now
Oncolytics Biotech Inc share price
ONCY price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:53 am GMT+0
ONCY price performance
-8.036%
5D
22.619%
1M
4.707%
YTD
80.702%
1Y
ONCY price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:53 am GMT+0
ONCY details
ONCY Market Signals